Ted D. Kellner v. AIM ImmunoTech Inc.
This text of Ted D. Kellner v. AIM ImmunoTech Inc. (Ted D. Kellner v. AIM ImmunoTech Inc.) is published on Counsel Stack Legal Research, covering Supreme Court of Delaware primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.
Opinion
EFiled: Jul 11 2024 03:04PM EDT Filing ID 73633189 Case Number 3,2024 IN THE SUPREME COURT OF THE STATE OF DELAWARE
TED D. KELLNER, § § No. 3, 2024 Plaintiff Below, § Appellant/Cross-Appellee, § Court Below: Court of Chancery § of the State of Delaware v. § § C.A. No. 2023-0879 AIM IMMUNOTECH INC., § THOMAS EQUELS, WILLIAM § MITCHELL, STEWART § APPELROUTH, and NANCY K. § BRYAN, § § Defendants Below, § Appellees/Cross- § Appellants. §
Submitted: April 10, 2024 Decided: July 11, 2024
Before SEITZ, Chief Justice; VALIHURA, TRAYNOR, LEGROW, and GRIFFITHS, Justices; constituting the Court en Banc.
Upon appeal from the Court of Chancery. AFFIRMED in part, REVERSED in part.
John M. Seaman, Esquire, Eliezer Y. Feinstein, Esquire, ABRAMS & BAYLISS LLP, Wilmington, Delaware; Teresa Goody Guillén, Esquire, Richard Raile, Esquire (argued), BAKER & HOSTETLER LLP, Washington, D.C.; Marco Molina, Esquire, BAKER & HOSTETLER LLP, Costa Mesa, California; Alexandra L. Trujillo, Esquire, BAKER & HOSTETLER LLP, Houston, Texas for Plaintiff Below, Appellant/Cross-Appellee Ted D. Kellner.
William R. Denny, Esquire, Matthew F. Davis, Esquire, Nicholas D. Mozal, Esquire, Caneel Radinson-Blasucci, Esquire, Eric J. Nascone, Esquire, POTTER ANDERSON & CORROON LLP, Wilmington, Delaware; Stefan Atkinson, Esquire (argued), Mary T. Reale, Esquire, Mason E. Reynolds, Esquire, Joseph Taglienti, Esquire, KIRKLAND & ELLIS LLP, New York, New York; Michael F. Williams, Esquire, Don Hong, Esquire, KIRKLAND & ELLIS LLP, Washington D.C. for Defendants Below, Appellees/Cross-Appellants AIM ImmunoTech Inc., Thomas Equels, William Mitchell, Stewart Appelrouth, and Nancy K. Bryan.
Brett M. McCartney, Esquire, Sarah T. Andrade, Esquire, BAYARD, P.A., Wilmington, Delaware; Edward J. Fuhr, Esquire, Steven M. Haas, Esquire, Johnathon E. Schronce, Esquire, James M. Lockerby, Esquire, HUNTON ANDREWS KURTH LLP, Richmond, Virginia for Amicus Curiae, Chamber of Commerce of the United States of America, in support of Appellees.
2 SEITZ, Chief Justice:
A group of AIM ImmunoTech, Inc. stockholders thought that the board of
directors was mismanaging the company. They launched an activism campaign and
proxy contest to elect new directors. The insurgents included two felons convicted
of wire fraud, insider trading, and other crimes. The campaign escalated into two
attempts to nominate directors to the AIM board.
The board rejected both nomination notices under its existing bylaws, which
led to a lawsuit over the second notice. The Court of Chancery denied the
insurgents’ request for a mandatory preliminary injunction to place their nominees
on the annual meeting ballot. The court held that factual disputes about the veracity
of the insurgents’ disclosures precluded temporary mandatory injunctive relief.
Undeterred, the insurgents reshuffled their membership, with Ted D. Kellner
leading a third attempt to nominate three new directors to the AIM board.
Meanwhile, the board amended its bylaws to include sweeping new advance notice
provisions. The amended bylaws required detailed disclosures by Kellner and his
nominees. Many of the amendments were approved by the AIM board as a direct
response to the insurgents’ campaign.
The AIM board once again rejected Kellner’s nominations for failing to
comply with the new advance notice bylaws. Kellner filed suit. After trial, the Court
of Chancery invalidated four of the six main advance notice bylaws and reinstated
3 the 2016 version of one of the invalidated bylaws. Ultimately, the court upheld the
board’s rejection of the third nomination notice because it failed to comply with the
two advance notice bylaws left standing, including the reinstated 2016 bylaw
provision.
On appeal, Kellner argues that the court improperly used the 2016 bylaw to
reject his notice because the AIM board did not rely on it as a basis for rejection. In
addition, according to Kellner, the enactment of the amended bylaws repealed the
2016 bylaw, which meant that the court had no basis to reinstate it. He also argues
that the court erred when it held that two of the amended bylaws withstood enhanced
scrutiny when, at the same time, the court found that many of the other bylaws were
preclusive and adopted for an improper purpose. Finally, Kellner contends that the
court erred when it found that the nomination notice did not comply with the
amended bylaws left standing.
By way of cross appeal, the defendants object to the Court of Chancery’s
invalidation of four of the amended bylaws. As they argue, the Court of Chancery
erred when it confused a “facial” challenge to the bylaws with an “as-applied”
challenge. According to the defendants, Kellner brought only an as-applied
challenge. The court, therefore, should not have invalidated the amended bylaws.
The defendants also contend that, in any event, the amended bylaws withstand
enhanced scrutiny review.
4 In a challenge to the adoption, amendment, or enforcement of a Delaware
corporation’s advance notice bylaws that is ripe for judicial review, the court should
consider the following: first, if contested, whether the advance notice bylaws are
valid as consistent with the certificate of incorporation, not prohibited by law, and
address a proper subject matter; and second, whether the board’s adoption,
amendment, or application of the advance notice bylaws were equitable under the
circumstances of the case.
Applying this framework to the current appeal, we hold that: (1) one
“unintelligible” bylaw is invalid; (2) the remaining amended advance notice bylaws
subject to this appeal are valid because they are consistent with the certificate of
incorporation, not prohibited by law, and address a proper subject matter; and (3)
the AIM board acted inequitably when it adopted the amended bylaws for the
primary purpose of interfering with, and ultimately rejecting, Kellner’s nominations.
Thus, the remaining bylaws challenged on appeal are unenforceable.
I.
A.
We rely on the facts as found after trial.1 AIM ImmunoTech, Inc. is a publicly
traded pharmaceutical company incorporated in Delaware and headquartered in
1 Kellner v. AIM ImmunoTech Inc., 307 A.3d 998 (Del. Ch. 2023).
5 Florida. AIM develops treatments for immune system disorders, viral diseases, and
cancers. Its lead product is the investigational drug Ampligen. AIM has a four-
member board of directors – Thomas Equels, William Mitchel, Stewart Appelrouth,
and Nancy K. Bryan. Equels is AIM’s Chief Executive Officer, having served in his
role since 2008. Mitchell, a scientist who has studied Ampligen since the 1980s, is
the chairman of the board. Appelrouth, an accountant, has served on the board since
2016. Bryan, the President of BioFlorida Inc., an LLC of which AIM is a member,
is the latest addition, beginning her board tenure in March, 2023. The directors and
the company are the defendants in the litigation.
Ted D. Kellner, the plaintiff in this litigation, is a retired founder, portfolio
manager, philanthropist, minority owner of a professional basketball team, and a
major AIM stockholder. In 2023, Kellner sought to nominate a competing slate of
directors to serve on the AIM board. The competing slate of directors was Kellner
himself, Todd Deutsch, and Robert Chioini. Deutsch, a private investor, has known
Kellner for over two decades and is the owner of about 3.5% of AIM’s shares.
Free access — add to your briefcase to read the full text and ask questions with AI
EFiled: Jul 11 2024 03:04PM EDT Filing ID 73633189 Case Number 3,2024 IN THE SUPREME COURT OF THE STATE OF DELAWARE
TED D. KELLNER, § § No. 3, 2024 Plaintiff Below, § Appellant/Cross-Appellee, § Court Below: Court of Chancery § of the State of Delaware v. § § C.A. No. 2023-0879 AIM IMMUNOTECH INC., § THOMAS EQUELS, WILLIAM § MITCHELL, STEWART § APPELROUTH, and NANCY K. § BRYAN, § § Defendants Below, § Appellees/Cross- § Appellants. §
Submitted: April 10, 2024 Decided: July 11, 2024
Before SEITZ, Chief Justice; VALIHURA, TRAYNOR, LEGROW, and GRIFFITHS, Justices; constituting the Court en Banc.
Upon appeal from the Court of Chancery. AFFIRMED in part, REVERSED in part.
John M. Seaman, Esquire, Eliezer Y. Feinstein, Esquire, ABRAMS & BAYLISS LLP, Wilmington, Delaware; Teresa Goody Guillén, Esquire, Richard Raile, Esquire (argued), BAKER & HOSTETLER LLP, Washington, D.C.; Marco Molina, Esquire, BAKER & HOSTETLER LLP, Costa Mesa, California; Alexandra L. Trujillo, Esquire, BAKER & HOSTETLER LLP, Houston, Texas for Plaintiff Below, Appellant/Cross-Appellee Ted D. Kellner.
William R. Denny, Esquire, Matthew F. Davis, Esquire, Nicholas D. Mozal, Esquire, Caneel Radinson-Blasucci, Esquire, Eric J. Nascone, Esquire, POTTER ANDERSON & CORROON LLP, Wilmington, Delaware; Stefan Atkinson, Esquire (argued), Mary T. Reale, Esquire, Mason E. Reynolds, Esquire, Joseph Taglienti, Esquire, KIRKLAND & ELLIS LLP, New York, New York; Michael F. Williams, Esquire, Don Hong, Esquire, KIRKLAND & ELLIS LLP, Washington D.C. for Defendants Below, Appellees/Cross-Appellants AIM ImmunoTech Inc., Thomas Equels, William Mitchell, Stewart Appelrouth, and Nancy K. Bryan.
Brett M. McCartney, Esquire, Sarah T. Andrade, Esquire, BAYARD, P.A., Wilmington, Delaware; Edward J. Fuhr, Esquire, Steven M. Haas, Esquire, Johnathon E. Schronce, Esquire, James M. Lockerby, Esquire, HUNTON ANDREWS KURTH LLP, Richmond, Virginia for Amicus Curiae, Chamber of Commerce of the United States of America, in support of Appellees.
2 SEITZ, Chief Justice:
A group of AIM ImmunoTech, Inc. stockholders thought that the board of
directors was mismanaging the company. They launched an activism campaign and
proxy contest to elect new directors. The insurgents included two felons convicted
of wire fraud, insider trading, and other crimes. The campaign escalated into two
attempts to nominate directors to the AIM board.
The board rejected both nomination notices under its existing bylaws, which
led to a lawsuit over the second notice. The Court of Chancery denied the
insurgents’ request for a mandatory preliminary injunction to place their nominees
on the annual meeting ballot. The court held that factual disputes about the veracity
of the insurgents’ disclosures precluded temporary mandatory injunctive relief.
Undeterred, the insurgents reshuffled their membership, with Ted D. Kellner
leading a third attempt to nominate three new directors to the AIM board.
Meanwhile, the board amended its bylaws to include sweeping new advance notice
provisions. The amended bylaws required detailed disclosures by Kellner and his
nominees. Many of the amendments were approved by the AIM board as a direct
response to the insurgents’ campaign.
The AIM board once again rejected Kellner’s nominations for failing to
comply with the new advance notice bylaws. Kellner filed suit. After trial, the Court
of Chancery invalidated four of the six main advance notice bylaws and reinstated
3 the 2016 version of one of the invalidated bylaws. Ultimately, the court upheld the
board’s rejection of the third nomination notice because it failed to comply with the
two advance notice bylaws left standing, including the reinstated 2016 bylaw
provision.
On appeal, Kellner argues that the court improperly used the 2016 bylaw to
reject his notice because the AIM board did not rely on it as a basis for rejection. In
addition, according to Kellner, the enactment of the amended bylaws repealed the
2016 bylaw, which meant that the court had no basis to reinstate it. He also argues
that the court erred when it held that two of the amended bylaws withstood enhanced
scrutiny when, at the same time, the court found that many of the other bylaws were
preclusive and adopted for an improper purpose. Finally, Kellner contends that the
court erred when it found that the nomination notice did not comply with the
amended bylaws left standing.
By way of cross appeal, the defendants object to the Court of Chancery’s
invalidation of four of the amended bylaws. As they argue, the Court of Chancery
erred when it confused a “facial” challenge to the bylaws with an “as-applied”
challenge. According to the defendants, Kellner brought only an as-applied
challenge. The court, therefore, should not have invalidated the amended bylaws.
The defendants also contend that, in any event, the amended bylaws withstand
enhanced scrutiny review.
4 In a challenge to the adoption, amendment, or enforcement of a Delaware
corporation’s advance notice bylaws that is ripe for judicial review, the court should
consider the following: first, if contested, whether the advance notice bylaws are
valid as consistent with the certificate of incorporation, not prohibited by law, and
address a proper subject matter; and second, whether the board’s adoption,
amendment, or application of the advance notice bylaws were equitable under the
circumstances of the case.
Applying this framework to the current appeal, we hold that: (1) one
“unintelligible” bylaw is invalid; (2) the remaining amended advance notice bylaws
subject to this appeal are valid because they are consistent with the certificate of
incorporation, not prohibited by law, and address a proper subject matter; and (3)
the AIM board acted inequitably when it adopted the amended bylaws for the
primary purpose of interfering with, and ultimately rejecting, Kellner’s nominations.
Thus, the remaining bylaws challenged on appeal are unenforceable.
I.
A.
We rely on the facts as found after trial.1 AIM ImmunoTech, Inc. is a publicly
traded pharmaceutical company incorporated in Delaware and headquartered in
1 Kellner v. AIM ImmunoTech Inc., 307 A.3d 998 (Del. Ch. 2023).
5 Florida. AIM develops treatments for immune system disorders, viral diseases, and
cancers. Its lead product is the investigational drug Ampligen. AIM has a four-
member board of directors – Thomas Equels, William Mitchel, Stewart Appelrouth,
and Nancy K. Bryan. Equels is AIM’s Chief Executive Officer, having served in his
role since 2008. Mitchell, a scientist who has studied Ampligen since the 1980s, is
the chairman of the board. Appelrouth, an accountant, has served on the board since
2016. Bryan, the President of BioFlorida Inc., an LLC of which AIM is a member,
is the latest addition, beginning her board tenure in March, 2023. The directors and
the company are the defendants in the litigation.
Ted D. Kellner, the plaintiff in this litigation, is a retired founder, portfolio
manager, philanthropist, minority owner of a professional basketball team, and a
major AIM stockholder. In 2023, Kellner sought to nominate a competing slate of
directors to serve on the AIM board. The competing slate of directors was Kellner
himself, Todd Deutsch, and Robert Chioini. Deutsch, a private investor, has known
Kellner for over two decades and is the owner of about 3.5% of AIM’s shares.
Chioini is the co-founder of Rockwell Medical Technologies, a dialysis company,
and was its Chief Executive Officer until the Rockwell board terminated his
employment in 2018. Chioini is not an AIM stockholder.
Deutsch and Chioini were both involved in a prior nomination effort led by
Franz Tudor – a business associate of Deutsch. The prior nomination dispute was
6 the subject of a separate and related Court of Chancery action – Jorgl v. AIM
ImmunoTech, Inc. – where Tudor led the effort to place nominees on AIM’s
universal proxy card.2 In 2009, Tudor pleaded guilty to securities fraud and insider
trading. Tudor is permanently enjoined from engaging in certain activities relating
to penny stocks – a class of microcap publicly-traded companies that includes AIM.
B.
Since 2016, AIM’s stock price has fallen precipitously. In the summer of
2020, Tudor contacted AIM management. He wanted to “be taken seriously.”3
Tudor told the board that he represented over one million AIM shares between his
ownership and the funds he consults. He sought a formal role with AIM. Equels
investigated Tudor’s past and discovered his criminal background.
When AIM management did not respond, Tudor attempted to contact other
directors and AIM representatives but, once again, was ignored. Tudor began to
represent to third parties that he was formally associated with AIM. In response,
AIM demanded that Tudor stop his misrepresentations. Tudor ignored the demand,
which caused AIM to file suit against him in Florida state court. Tudor eventually
2 Jorgl v. AIM ImmunoTech Inc., 2022 WL 16543834 (Del. Ch. Oct. 28, 2022). 3 Kellner, 307 A.3d at 1007 (quoting the record).
7 agreed to a stipulated permanent injunction, which enjoined Tudor from contacting
any of AIM’s business relationships regarding AIM or its products and activities.4
Other Tudor associates joined the pressure campaign. Deutsch, Tudor’s
former colleague, who had suffered significant losses from his AIM investment,
began working with Tudor to engage with the board. Tudor also recruited others to
the activism effort: Chioini – whom he had worked with at Rockwell – and
acquaintances Daniel Ring and Walter Lautz. Lautz sent AIM a notice to nominate
Ring and Chioini to the board. Tudor drafted the notice without Lautz’s review. It
did not mention Tudor or his involvement in the nomination.
The AIM board rejected Lautz’s notice for noncompliance with federal
securities law. In reaction to the rejection, Chioini sought financial support from his
fellow Rockwell co-founder, Michael Xirinachs. Later, in the same year, Xirinachs
pleaded guilty to criminal charges involving fraudulent securities trading, promotion
and material misrepresentations to investors, and misuse of funds.
Chioini sent Xirinachs a copy of AIM’s bylaws and flagged the advance notice
provisions. Tudor began working with counsel at Baker & Hostetler LLP on a
4 AIM ImmunoTech, Inc. v. Tudor, No. 21-CA-393 (Fla. Cir. Ct. Aug. 13, 2021) (order granting permanent injunction).
8 potential proxy contest. He continued to contact AIM about his nomination effort.
Tudor was met with silence to which he responded, “you now get the gloves off.”5
Meanwhile Deutsch kept Kellner, his fellow AIM stockholder, apprised of the
nomination effort. Kellner first purchased AIM stock in early 2021 at Deutsch’s
suggestion. Deutsch would send Kellner information from Tudor about AIM’s stock
performance – mostly by forwarding him emails written by Tudor. Kellner saw
promise in AIM but, like the other insurgents, thought it was mismanaged. One day
after the Lautz nomination notice, Deutsch sent Kellner an investment analysis
prepared by Tudor. Kellner marked up the analysis by hand and scribbled “48
million shares. What do we own? 15 to 18%[?]”6 Kellner was later surprised to
learn that Tudor owned significantly fewer shares than Kellner had believed.
Deutsch vouched for Tudor, stating “I promise [you] he is as smart [as] they come
in [the] space.”7 Kellner answered that Tudor “doesn’t need to worry nor you about
Teddy!!![13 emojis, including thumbs up and smiley faces].”8
At this point the nomination effort hit another obstacle. Tudor expected Lautz
to submit a new nomination notice to the board. But Lautz told Tudor that he had
5 Kellner, 307 A.3d at 1010 (quoting the record). 6 Id. at 1009 (quoting the record). 7 Id. at 1011 (quoting the record). 8 Id. (alteration in original) (quoting the record).
9 been the subject of “a FINRA investigation” and “was terminated from one of the
largest brokerage houses on the planet,” which “may not be a good look” for the
nomination effort.9 AIM’s counsel later told Deutsch, Kellner, and Tudor’s counsel
that they had to comply with Section 13(d) of the Securities and Exchange Act of
1934. The advice came about after counsel learned that Deutsch was attempting to
have Tudor attend “as an undisclosed party, a telephone conference between AIM’s
[investor relations] firm,” Deutsch, and Kellner.10 The AIM communication
revealed to Kellner, for the first time, that Tudor was a felon subject to a permanent
injunction against AIM.11 Kellner hand wrote on a printed copy of AIM’s letter,
“FRANZ TUDOR – IS A FELON?” and “INSIDER TRADING?”12 Kellner also
wrote the names “Robb [sic] Chioini” and “Michael Zeaniack [Xirinachs],” noting:
“our plans – get a lawyer.”13
Ring dropped out and with Lautz no longer the nominator, the nomination
effort needed both a stockholder to make the nomination and a new nominee.
Chioini recruited a business associate, Michael Rice, to be his co-nominee. Rice
9 Id. at 1011 (quoting the record). 10 Id. (alteration in original) (quoting the record). 11 Id. at 1012. 12 Id. (quoting the record). 13 Id. (quoting the record).
10 supplied the face of the investor, a friend he surfed with – Jonathan Jorgl. Jorgl had
never heard of AIM when Rice made his request. Rice and Xirinachs made sure that
Jorgl held shares recorded to his name before the nomination deadline.
On July 8, 2022, Jorgl submitted a notice with Chioini and Rice as his
proposed nominees. Shortly thereafter, AIM rejected Jorgl’s nomination notice
because the notice, as AIM’s General Counsel put it, “fail[ed] to satisfy Section 1.4
of [AIM’s] [b]ylaws and applicable law by, among other things, making false and
misleading statements in lieu of providing [the required] information.”14 Section
1.4(c) of AIM’s bylaws, as adopted in 2016, required a stockholder proposal to
disclose “arrangements or understandings . . . pursuant to which the nomination(s)
are to be made.”15
AIM’s rejection triggered the first round of litigation in the Court of Chancery,
Jorgl v. AIM ImmunoTech, Inc.16 Following expedited discovery, the court declined
to grant Jorgl judgment as a matter of law because, on the record before it, the court
could not conclude that Jorgl’s nomination notice complied with the existing bylaw
requirements. The court also concluded that the “swirl of lingering factual disputes”
14 Id. at 1013 (alterations in original) (quoting the record). 15 Id. (quoting the record). 16 2022 WL 16543834.
11 also precluded mandatory preliminary injunctive relief.17 AIM continued to
prosecute claims in Florida against Tudor, Deutsch, Kellner, Jorgl, Lautz, Chioini,
and Rice. In the Florida action, AIM alleged that the investor group violated Section
13(d) of the Exchange Act – later amending its complaint to drop Chioini and Rice.
AIM sought an injunction against the group to prohibit them from further violating
federal securities law.18
Meanwhile, Kellner prepared for AIM’s 2022 annual meeting. He drafted an
update to his college investment club, for which he managed the investment
portfolio, which included AIM stock. In the update, Kellner said he was “now a
party to that proxy fight.”19 Kellner attended AIM’s annual meeting in person. He
was disappointed by the lack of engagement and felt “angry” over what had
occurred.20 Kellner reached out to the investment group to gauge their level of
commitment to continue their nomination efforts.
C.
Following the 2022 annual meeting, the AIM board took a new look at its
governance structure. In response to stockholder feedback, the board sought to add
17 Id. at *17. 18 AIM ImmunoTech, Inc. v. Tudor et al., No. 5:22-cv-323 (M.D. Fla.). The court dismissed the complaint as moot following the 2022 annual meeting. 19 Kellner, 307 A.3d at 1013 (quoting the record). 20 Id. at 1014 (quoting the record).
12 additional directors who would “bring diversity and additional biotechnology
commercialization experience.”21 Chioini viewed this as an opportunity to get onto
the board. He instructed his counsel, John Harrington of BakerHostetler, to relay to
AIM his and Rice’s continued interest. Harrington informed AIM’s Delaware
counsel at Potter Anderson & Corroon LLP that Chioini and Rice wanted to “avoid
another proxy contest” and instead would be amenable to “mutually agreeable
directors” joining the board.22 Harrington stressed that they were otherwise “ready
to come out guns blazing” next year.23 Soon after, Chioini and Kellner spoke for the
first time. Chioini told Harrington that Kellner was “very interested in working with
[them] to remove these guys” and “want[ed] to keep in touch.”24
Before the 2023 annual meeting, the board considered amendments to AIM’s
advance notice bylaws. The board engaged Potter Anderson for the review. Potter
Anderson circulated a proposed set of amendments. The proposed bylaw
amendments were intended to respond “to significant activist activity during 2022
in which an activist group . . . engag[ed] in efforts to conceal who was supporting
and who was funding the nomination efforts and to conceal the group’s plans for the
21 Id. (quoting the record). 22 Id. at 1015 (quoting the record). 23 Id. (quoting the record). 24 Id. (alterations in original) (quoting the record).
13 Company,” and to modernize and bring the bylaws in line with recent amendments
to the Delaware General Corporation Law (“DGCL”) and federal law.25 Potter
Anderson presented the amendments at a board meeting where counsel discussed
the Jorgl nomination. The board concluded that the bylaw provisions were not
“preclusive or unreasonably restrictive” of stockholders’ ability to make proposals
or nominations.26 The board made minor changes and thereafter adopted the bylaws
by unanimous vote (the “Amended Bylaws”).27
As the third nomination effort commenced, Tudor, who was supposedly
employed by Deutsch to do back-office tasks, dropped out of sight. The remaining
individuals were Kellner, Deutsch, Chioini, and Rice. They met with their counsel
to strategize. Kellner promised to fund the effort if Chioini and Deutsch also made
a smaller contribution. Kellner, Deutsch, and Chioini signed an engagement letter
with BakerHostetler.28
BakerHostetler contacted AIM on Kellner’s behalf to request the company’s
director and officer (D&O) questionnaire and a representation and agreement
referred to in the Amended Bylaws. The Amended Bylaws gave AIM five days to
25 Id. at 1016 (quoting the record). 26 Id. (quoting the record). 27 A408. 28 A541.
14 complete and send the questionnaire, during which the board revised the
questionnaire to require additional information from Kellner and his nominees.
Kellner submitted a Schedule 13D filing with the Securities and Exchange
Commission. Equels contacted the board to schedule a discussion about the “second
attempt of [a] hostile takeover.”29 On August 3, 2023, the evening before the
nomination deadline – Kellner submitted his notice that he intended to nominate
himself, Chioini, and Deutsch as director candidates at the 2023 annual meeting.30
The twenty-page notice contained lengthy disclosures.31 It contained
information regarding the nominees such as: biographical details;32 employment
history;33 group agreements;34 statements on affiliations with Lautz, Tudor, Rice,
Jorgl, and Xirinachs;35 prior board service;36 meeting dates;37 equity ownership in
29 Kellner, 307 A.3d at 1018 (alteration in original) (quoting the record). 30 A683. 31 A683–702. 32 A685. 33 Id. 34 A688. 35 A690–91. 36 A692. 37 A693.
15 AIM and its competitors by the nominees and their families;38 and intent to solicit
stockholders.39 Notably, the notice rejected the existence of any sort of agreement,
arrangement, or understanding (“AAU”) involving Tudor for the Jorgl nomination;40
disclosed that Chioini had no AAUs with Lautz or Tudor, despite Chioini having
been nominated by Lautz in the invalid 2022 attempt;41 disclosed no AAUs of
Chioini despite Chioini incurring significant legal fees with no equity ownership of
AIM stock;42 and did not disclose any AAU of Xirinachs, despite his financial
support of the activist effort.
The nominees’ D&O questionnaires contained information regarding the
nominees such as their: educational background;43 trade qualifications;44 prior board
38 A697–99. 39 A701. 40 A690. 41 Id. 42 A689. 43 A717. 44 Id.
16 service;45 criminal history;46 financial information;47 regulatory action;48 diversity;49
group agreements;50 economic interest in the nomination;51 and social media
presence.52
Four days later, AIM’s outside communications advisor sent a draft press
release concerning the nomination to Equels, AIM’s counsel, and AIM’s investor
relations team. The draft stated, “[a] hostile takeover of the Board would not only
put shareholders’ investments at risk, it would also be detrimental to the patients for
whom we are working to bring new life-saving oncology therapies to market – most
notably by repurposing our lead drug, Ampligen.”53 Counsel recommended
revisions to the messaging as “no determination ha[d] been made yet as to whether
the notice complies with AIM’s advance notice bylaws.”54
45 A718. 46 Id. 47 Id. 48 A722. 49 A724. 50 A730. 51 A732. 52 A733. 53 Kellner, 307 A.3d at 1018 (alteration in original) (quoting the record). 54 Id. (alteration in original) (quoting the record).
17 The board met over three sessions in a two-week period to discuss the
nomination. In an August 8 meeting, Equels emphasized that “protecting
stockholders was paramount” considering the overlapping people between the prior
and current nomination efforts and their troubling backgrounds.55 The board hired
Potter Anderson and Kirkland & Ellis LLP to evaluate the notice. In addition, AIM
filed a motion seeking to revive the dismissed Florida action, characterizing the
Kellner notice as misleading and a continuation of the 2022 activism.56 Based on
the omissions and misstatements, AIM’s complaint characterized Kellner, Deutsch,
and the other group members as posing an “ongoing . . . threat to AIM and its
shareholders.”57
At the August 21 meeting, counsel advised the board that the Kellner notice
did not comply with the Amended Bylaws. Specifically, absent from the notice, as
interpreted by counsel, were: (1) undisclosed AAUs among the activists; (2)
disclosure of known supporters of the nomination; (3) disclosure of the specific date,
rather than windows of time, of first contact between the activists; and (4) other
information, such as past adverse recommendations for public board service from
independent proxy advisory firms. After explaining the purported deficiencies,
55 Id. at 1019 (quoting the record). 56 AIM ImmunoTech, Inc. v. Tudor et al., No. 5:22-cv-323 (M.D. Fla.). The motion was denied. 57 Kellner, 307 A.3d at 1019 (quoting the record).
18 counsel reviewed litigation options with the board. The board concluded that it
required additional time to consider its course of action.
The following morning, the board reconvened to reject unanimously Kellner’s
nomination notice for not complying with the Amended Bylaws. The board
concluded that the notice was “designed to omit and conceal information and to
provide incomplete or misleading disclosures that destabilize the important
disclosure function that [AIM’s] Advance Notice Provisions were designed to
serve.”58 The board authorized a letter to notify Kellner of the rejection. AIM’s
counsel notified BakerHostetler of the rejection by letter.59 The rejection letter sent
to Kellner, which explained the various disclosure deficiencies, stated that the
deadline for submitting a timely notice had passed. The board would not, therefore,
consider an updated notice for the 2023 annual meeting. Kellner issued a press
release announcing that he had filed litigation and urged AIM stockholders to
disregard board proxy contest communications.
The rejection letter described several instances of non-compliance with AIM’s
bylaws – but was primarily focused on the deficient disclosure of AAUs.60 The
notice alleged that Kellner failed to disclose various AAUs relating to the 2022 and
58 Id. at 1020 (alteration in original) (quoting the record). 59 A1055. 60 A1055–68.
19 2023 annual meetings.61 Among other things, AIM found it not credible that
nominee Chioini had no AAUs other than the July 2023 agreement based on the
factual history between the company and the insurgents, as well as the fact that
Chioini owned no shares of AIM and expended both time and money on the
nomination effort.62 Similarly, AIM doubted that Xirinachs lacked AAUs given his
extensive history of working with Chioini and Tudor on nominating new board
members.63
Additionally, the letter identified “other” instances of “material” omissions,
such as: providing materially false information regarding nominee qualifications;64
material omission of nominee biographical information;65 failure to disclose certain
affiliations;66 failure to disclose certain ownership information;67 failure to disclose
61 A1057, 59. 62 A1060. 63 Id. 64 Id. 65 A1062. 66 Id. 67 A0163.
20 relevant dates;68 failure to disclose information required by the proxy rules;69 and
making an inaccurate certification regarding compliance with legal requirements.70
D.
Kellner filed a complaint in the Court of Chancery, naming AIM and its board
members as defendants.71 In his complaint, Kellner asked for declarations that the
Amended Bylaws are unlawful, or in addition and in the alternative, that the
defendants’ application of the bylaws to reject his notice is unlawful and/or
inequitable; that each of Equels, Mitchell, and Appelrouth breached their fiduciary
duties by adopting the Amended Bylaws; and that the board breached its fiduciary
duties by rejecting the notice under the Amended Bylaws.72 The defendants
answered and counterclaimed against Kellner, seeking declarations that: the
Amended Bylaws are lawful and valid; the notice did not comply with the Amended
Bylaws; the notice was lawfully and validly rejected for failing to comply with the
Amended Bylaws; and that AIM’s directors did not breach their fiduciary duties by
68 A1064. 69 Id. 70 A1067. 71 B588. 72 B635.
21 adopting the Amended Bylaws or by rejecting Kellner’s notice.73 Following a three-
day expedited trial, the court concluded that many of the provisions in the Amended
Bylaws were invalid, but the board’s rejection of Kellner’s nominations was
nevertheless equitable.74
First, the court determined that the Amended Bylaws were not adopted on a
clear day.75 As such, the court treated the Amended Bylaws adoption as a defensive
measure, applied the enhanced scrutiny standard of review, and placed the burden
of proof on the defendants.76 The court focused its analysis on six bylaws used to
support the notice’s rejection:
• Section 1.4(c)(1)(D), “the AAU Provision,” requiring “a complete and accurate description of all agreements, arrangements or understandings [AAUs] (whether written or oral, and including promises)” between a broadly defined group of people including any “Holder” and “Stockholder Associated Person [SAP],” “with respect to the nominations or [AIM] . . . existing presently or existing during the prior twenty-four (24) months . . . .”77
o A Holder is defined as “the Noticing Stockholder and each beneficial owner, if any, on whose behalf the nomination is made or other business is being proposed.”78
73 Dfs.’ Ans. Ver. Compl. and Ver. CC. at 100. 74 Kellner, 307 A.3d at 1045. 75 Id. at 1024. 76 Id. 77 A409. 78 A412.
22 o A SAP is defined “as to any Holder, (i) any person acting in concert with such Holder with respect to the Stockholder Proposal or the Corporation, (ii) any person controlling, controlled by, or under common control with such Holder or any of their respective Affiliates and Associates, or a person acting in concert therewith with respect to the Stockholder Proposal or the Corporation, and (iii) any member of the immediate family of such Holder or an Affiliate or Associate of such Holder.”79
• Section 1.4(c)(1)(E), “the Consulting/Nomination Provision,” requiring disclosure of AAUs “between or among each Holder and/or any Stockholder Associated Person . . . to consult or advise on any investment or potential investment in a publicly listed company . . . and/or . . . to nominate, submit, or otherwise recommend the Stockholder Nominee for appointment, election or re-election . . . to any officer, executive officer or director role of any publicly listed company . . . during the past ten (10) years . . . .”80
• Section 1.4(c)(4), “the Known Supporter Provision,” requiring the names and contact info “of other stockholders . . . known by any Holder or Stockholder Associated Person to support such Stockholder Proposal or Stockholder Proposals . . . .”81
• Section 1.4(c)(3)(B), “the Ownership Provision,” a 1,099-word run-on sentence of 13 subsections, requiring, among other things, disclosures relating to ownership of any equity interest in AIM and “any principal competitor” of AIM, by a broadly defined group of people including SAPs.82
• Section 1.4(c)(1)(H), “the First Contact Provision,” requiring “the dates of first contact between any Holder and/or Stockholder Associated Person, on the one hand, and the Stockholder Nominee, on the other hand, with respect 79 Id. 80 A409. 81 A411. 82 A410. Mitchell, AIM’s board chair, testified that if the directors had read the bylaw “line by line” they “would still be in the meeting.” Kellner, 307 A.3d at 1034 (quoting the record). Like AIM’s board, we will not lengthen this opinion by reviewing line-by-line the Ownership Provision’s requirements.
23 to (i) [AIM] and (ii) any proposed nomination or nominations of any person or persons (including, without limitation, any Stockholder Nominee) for election or re-election to the Board of Directors.”83
• Sections 1.4(c)(1)(L) and 1.4(e), “the Questionnaire Provisions,” requiring director nominees to complete a form of the D&O questionnaire. Upon request for a form questionnaire, the corporate secretary must issue the form within five business days. The form questionnaire required disclosure, “to the extent known” of any adverse recommendations by proxy advisory firms.84 Next, the court considered whether the board responded to a legitimate
threat.85 The court held that, given the composition and history of the insurgent
group, the board was reasonable when it concluded that it faced a threat to its
objective of gathering complete information regarding director nominations,
including the identity of those making and supporting the nominations.86
The court reviewed next whether the board’s defensive acts were reasonable
and not preclusive of a proxy contest.87 After engaging in a context-specific analysis
of each of the six provisions, the court held that four of the six challenged bylaws
were inequitable and “facially invalid.” The four invalidated bylaws, and the court’s
reasoning, follow:
83 A409. 84 A410–11. 85 Kellner, 307 A.3d at 1025–26 (citing Coster v. UIP, 300 A.3d 656 (Del. 2023)). 86 Id. at 1026. 87 Id. at 1027.
24 • The AAU Provision was more “akin to tripwire than an information gathering tool.”88 The bylaw’s disclosure requirements coupled with the definition of a SAP resulted in vague and overbroad requirements ripe for subjective interpretation by the board.89
• The Consulting/Nomination Provision imposed ambiguous and onerous requirements across a lengthy term. The provision contains the same SAP requirement as the AAU and goes even further than the AAU, by requesting any investment advice involving any public company over a ten-year term. The court concluded that “[a]t worst, it is draconian,” because “it would give the board license to reject a notice based on a subjective interpretation of the provision’s imprecise terms.”90
• The Known Supporter Provision was vague about what qualifies as “support.” A similar bylaw, which withstood scrutiny in a separate action in the Court of Chancery, only requested “financial” information. The bylaw here was unqualified in the nature of the support sought, and therefore impeded the stockholder franchise.91
• The Ownership Provision was “indecipherable” and seemingly designed to preclude a proxy contest.”92
The court found that the First Contact and Questionnaire Provisions survived
enhanced scrutiny review. As the court held, the First Contact Provision was not
preclusive because the information requested was readily discernible.93 And Kellner
88 Id. at 1030. 89 Id. 90 Id. at 1031. 91 Id. at 1032 (citing Rosenbaum v. CytoDyn, Inc., 2021 WL 4775140, at *19 (Del. Ch. Oct. 13, 2021)). 92 Id. at 1034. 93 Id. at 1035.
25 only challenged the timing aspect of the Questionnaire Provisions, which the court
held was reasonable.94
After finding the AAU Provision “invalid,” the court reverted to AIM’s prior,
valid AAU version.95 The 2016 AAU Provision, which the court reviewed in the
Jorgl litigation and was a subset of the 2023 AAU Provision, lacked the SAP terms
which rendered the 2023 AAU Provision inequitable.96 Central to the court’s
reasoning was that “[g]iven the vital corporate considerations at risk if nominating
stockholders conceal AAUs, it would risk further inequity to excuse the Kellner
Notice from disclosing them when AIM had a validly enacted provision in place pre-
amendment.”97
The court then held that Kellner’s notice and the director nominees’ D&O
responses did not comply with the 2016 AAU Provision, the First Contact Provision,
and the Questionnaire Provisions. Specifically, the court ruled that: the notice was
misleading because it did not disclose the actual date when an AAU among Kellner,
94 Id. at 1036. 95 Id. at 1038 (citing Hollinger Int’l, Inc. v. Black, 844 A.2d 1022 (Del. Ch. 2004), aff’d, 872 A.2d 559 (Del. 2005); Rainbow Mountain, Inc. v. Begeman, 2017 WL 1097143 (Del. Ch. Mar. 23, 2017)). 96 Id. (citing Jorgl, 2022 WL 16543834, at *11); A277–78. 97 Kellner, 307 A.3d at 1038.
26 Deutsch, and Chioini arose;98 Kellner did not disclose the date of his first contact
with Deutsch and only provided a vague date for his contact with Chioini;99 and the
D&O responses were false as all three of the nominees had prior adverse
recommendations from proxy advisors.100 In light of the noncompliance with the
prior version of the bylaws, the court held that, after applying enhanced scrutiny, the
board acted reasonably when it rejected Kellner’s notice.101 The court also found
that the board’s actions were not manipulative nor was the rejection “preordained,”
and the nominees were the ones engaging in manipulative conduct.102
The Court of Chancery concluded as follows: “[r]egarding Kellner’s claim
concerning the validity of the Amended Bylaws and AIM’s counterclaim, judgment
is entered for Kellner in part and for AIM in part. Regarding Kellner’s claim
concerning his compliance with the Amended Bylaws and the board’s rejection of
the Kellner Notice, judgment is entered in favor of the defendants.”103
98 Id. at 1040. 99 Id. at 1041. 100 Id. 101 Id. at 1042–43. 102 Id. at 1043–44. 103 Id. at 1044–45.
27 E.
Kellner raises three issues on appeal.104 First, he claims that the court
erroneously determined that his notice was deficient under the 2016 AAU
Provision.105 He argues that the board did not rely on the 2016 AAU Provision to
reject his notice, and therefore the court cannot apply an after-the-fact reason for the
board’s rejection.106 In the alternative, he argues that the 2016 AAU Provision was
repealed in March 2023 and therefore cannot support the rejection many months
later.107
Next, according to Kellner, the court erred by concluding that certain bylaw
amendments satisfied enhanced scrutiny.108 He argues that the court failed to
evaluate “inextricably related bylaws together” and that it cannot be the case that
some bylaws were inequitably designed to thwart the nomination effort while others
supported an equitable rejection of the notice.109 And regardless, he claims, the
isolated provisions the court upheld fail enhanced scrutiny.110
104 Opening Br. at 3. 105 Id.at 12. 106 Id. 107 Id. at 15. 108 Id. at 18. 109 Id. at 19 (citing Unitrin, Inc. v. Am. Gen. Corp., 651 A.2d 1361, 1387 (Del. 1995)). 110 Id. at 27.
28 Kellner also argues that the First Contact Provision is inequitable because it
serves no important corporate interest, is preclusive, and unreasonable.111 Further,
according to Kellner, the Questionnaire Provisions solicited unimportant
information and the five-business-day window to produce the questionnaire allowed
for gamesmanship by the board.112 Kellner points out that the court did not address
the portion of Kellner’s complaint that sought a declaration that the board violated
its fiduciary duties – despite finding four of the bylaws inequitable.113
Finally, Kellner argues that the court erroneously upheld the rejection by not
applying the Amended Bylaws properly to the notice.114 He contends that his notice
complied in all material respects with the 2016 AAU Provision and would have
ensured an informed stockholder vote.115 Kellner also argues that the notice
complied with the First Contact Provision and Questionnaire Provisions by
providing the dates of first contact, and that the nominees disclosed the adverse
recommendations by proxy advisors “to the extent known.”116
111 Id. 112 Id. at 29. 113 Id. at 31. 114 Id. at 32. 115 Id. at 33, 37. 116 Id. at 43–44.
29 The defendants raise three issues on cross-appeal and ask that we affirm the
rest of the court’s decision.117 First, they contend that the court misconstrued
Kellner’s as-applied challenge as a facial challenge.118 According to the defendants,
Kellner made only an as-applied challenge.119 Second, they claim the court
misapplied the facial validity standard.120 The defendants argue that, under
Delaware law, bylaws are presumed valid, and the burden is on the plaintiff to
demonstrate that they “‘cannot operate lawfully or equitably under any
circumstances.’”121 As such, the court erred when it invalidated four of the Amended
Bylaws by applying enhanced scrutiny. And third, they argue that the court erred
by finding that four provisions of the Amended Bylaws failed enhanced scrutiny
review because they are all proportional to the threat of an uninformed stockholder
vote.122
On appeal, we accept the court’s factual findings if they are “sufficiently
supported by the record and are the product of an orderly and logical deductive
117 Answering Br. at 6. 118 Id. at 27. 119 Id. 120 Id. at 30. 121 Id. (quoting Salzberg v. Sciabacucchi, 227 A.3d 102, 113 (Del. 2020)). 122 Id. at 34–40.
30 process.”123 Only when they are “clearly wrong and the doing of justice requires
their overturn” are we “free to make contradictory findings of fact.”124 We review
de novo the court’s legal conclusions.125 We review the results of the court’s
enhanced scrutiny analysis and interpretation of corporate bylaws de novo.126
II.
The DGCL is broadly enabling and offers “immense freedom for businesses
to adopt the most appropriate terms for the organization, finance, and governance of
their enterprise.”127 Consistent with this legislative choice, the DGCL places
minimal procedural and substantive requirements on stockholders and directors
when addressing bylaws.128 As a matter of procedure, stockholders have the “power
to adopt, amend or repeal bylaws,”129 and directors may do so if authorized by the
123 Levitt v. Bouvier, 287 A.2d 671, 673 (Del. 1972). 124 Id. 125 Coster, 300 A.3d at 663. 126 Id.; Airgas, Inc. v. Air Prod. & Chemicals, Inc., 8 A.3d 1182, 1188 (Del. 2010). 127 Salzberg, 227 A.3d at 116. 128 See 8 Del. C. § 211(b) (“Unless directors are elected by written consent in lieu of an annual meeting as permitted by this subsection, an annual meeting of stockholders shall be held for the election of directors on a date and at a time designated by or in the manner provided in the bylaws.”); id. § 211(e) (“All elections of directors shall be by written ballot unless otherwise provided in the certificate of incorporation; if authorized by the board of directors . . . .”). 129 8 Del. C. § 109(a). This power must be read with Section 141(a) of the DGCL. CA, Inc. v. AFSCME Emps. Pension Plan, 953 A.2d 227, 232 (Del. 2008) (“[T]he shareholders’ statutory power to adopt, amend or repeal bylaws is not coextensive with the board’s concurrent power and is limited by the board’s management prerogatives under Section 141(a).”).
31 certificate of incorporation.130 As a matter of substance, bylaws “may contain any
provision, not inconsistent with law or with the certificate of incorporation, relating
to the business of the corporation, the conduct of its affairs, and its rights or powers
or the rights or powers of its stockholders, directors, officers or employees.”131
Advance notice bylaws require stockholders to provide the board with prior
notice of, and information about, their director nominations. They are “designed and
function to permit orderly meetings and election contests and to provide fair warning
to the corporation so that it may have sufficient time to respond to shareholder
nominations.”132 Advance notice bylaws assist the board’s “information-gathering
and disclosure functions, allowing boards of directors to knowledgeably make
recommendations about nominees and ensuring that stockholders cast well-informed
130 8 Del. C. § 109(a) (“[A]ny corporation may, in its certificate of incorporation, confer the power to adopt, amend or repeal bylaws upon the directors . . . .”). As a result of Section 109’s enabling language, stockholders, through the certificate of incorporation, may “assent to not having to assent to board-adopted bylaws.” Boilermakers Loc. 154 Ret. Fund & Key W. Police & Fire Pension Fund v. Chevron Corp., 73 A.3d 934, 956 (Del. Ch. 2013) (citing CA, 953 A.2d at 231). Regardless of the authority vested in the board, stockholders retain the power to adopt and amend bylaws and may repeal bylaws adopted by the board. Id. 131 8 Del. C. § 109(b). 132 Openwave Sys. Inc. v. Harbinger Cap. Partners Master Fund I, Ltd., 924 A.2d 228, 239 (Del. Ch. 2007).
32 votes.”133 They have evolved over time to meet changing market conditions and to
adjust to evolving federal securities regulations.134
Under Delaware law, bylaws are “presumed to be valid” and must be
interpreted “in a manner consistent with the law.”135 A facially valid bylaw is one
that is “authorized by the Delaware General Corporation Law (DGCL), consistent
with the corporation’s certificate of incorporation, and not otherwise prohibited.”136
When a bylaw is challenged in court, it is insufficient for a plaintiff to simply assert
that “under some circumstances, a bylaw might conflict with a statute, or operate
133 Paragon Techs., Inc. v. Cryan, 2023 WL 8269200, at *7 (Del. Ch. Nov. 30, 2023) (internal quotation marks omitted). 134 Early advance notice bylaws required advance notice of the nomination accompanied by basic information. Donald F. Parsons & Jason S. Tyler, Activist Stockholders, Corporate Governance Challenges, and Delaware Law, RESEARCH HANDBOOK ON MERGERS AND ACQUISITIONS 7 n.13 (Claire A. Hill & Steven Davidoff Solomon eds., 2016). Over time, bylaws imposed more onerous disclosure requirements about the stockholder nominator and nominees. Id. The information sought typically related to the nominator’s financial positions with respect to the company, such as any derivative positions held, and the identities of persons acting in concert with the nomination group. Id. Until recently, dissident stockholders had a separate proxy card, meaning stockholders could only vote between competing slates. In 2021, the SEC adopted Rule 14a-19, which mandated a single universal proxy card. It allowed stockholders to pick directors from both the incumbent and rival slates from the same card. 17 CFR § 240.14a-19. The universal proxy rules prompted further evolution of advance notice bylaws to better conform to the rules. Aaron Wendt & Krishna Shah, 2023 Proxy Season Briefing: Key Trends and Data Highlights, Harvard Law School Forum on Corporate Governance (Aug. 17, 2023), https://corpgov.law.harvard.edu/2023/08/17/2023-proxy-season-briefing-key-trends-and-data- highlight/ (“More than 685 companies in our coverage amended advance notice bylaws in response to universal proxy[.]”). 135 Frantz Mfg. Co. v. EAC Indus., 501 A.2d 401, 407 (Del. 1985). 136 ATP, 91 A.3d at 557–58.
33 unlawfully.”137 Instead, the plaintiff must demonstrate that the bylaw cannot operate
lawfully under any set of circumstances.138
Even if facial validity is not at issue, bylaws are still subject to judicial review.
If the court has before it a “genuine, extant controversy” involving the adoption,
amendment, or application of bylaws, the Court of Chancery reviews corporate acts
not only for their legality but also for their equity.139 The General Assembly’s
“capacious grant of power is policed in large part by the common law of equity, in
the form of fiduciary duty principles.”140 As we have repeated time and again since
137 Id. 138 Id. See also Salzberg, 227 A.3d at 113 (“[T]he plaintiff must show that the charter provisions ‘cannot operate lawfully or equitably under any circumstances.’ Plaintiffs must demonstrate that the charter provisions ‘do not address proper subject matters’ as defined by statute, ‘and can never operate consistently with law.’” (quoting Cedarview Opportunities Master Fund, L.P. v. Spanish Broad. Sys., Inc., 2018 WL 4057012, at *20 (Del. Ch. Aug. 27, 2018); Boilermakers, 73 A.3d at 949)). 139 Boilermakers, 73 A.3d at 949 (“Thus, a plaintiff can challenge the real-world enforcement of a forum selection bylaw. But that review happens when there is a genuine, extant controversy in which the forum selection bylaw is being applied.”). A court should only hear bylaw adoption, amendment, and application claims that are “ripe for judicial determination.” Stroud v. Milliken Enterprises, Inc., 552 A.2d 476, 480 (Del. 1989). A bylaw dispute is ripe when litigation is “unavoidable” and the “material facts are static.” Id. at 481 (citing Stabler v. Ramsay, 88 A.2d 546, 550 (Del. 1952); Rollins Int’l, Inc. v. Int’l Hydronics Corp., 303 A.2d 660, 662 (Del. 1973)). Fiduciary review standards are meant to address “real-world concerns when they arise in real- world and extant disputes, rather than hypothetical and imagined future ones.” Boilermakers, 73 A.3d at 963. Here, the AIM board amended its bylaws during a prolonged proxy contest with dissidents, and ultimately used those bylaws to keep the insurgents off the ballot. The defendants have not argued that the dispute is premature for adjudication. 140 Hollinger, 844 A.2d at 1078.
34 our 1971 decision in Schnell v. Chris-Craft Industries, Inc., “inequitable action does
not become permissible simply because it is legally possible.”141 In other words,
when corporate action is challenged, it must be twice-tested – first for legal
authorization, and second by equity.142 The same principles apply to board-adopted
advance notice bylaws.
Delaware courts scrutinize closely corporate acts that affect stockholder
voting. As Chancellor Allen famously stated in Blasius Industries, Inc. v. Atlas
Corp., “[t]he shareholder franchise is the ideological underpinning upon which the
legitimacy of directorial power rests.”143 Advance notice bylaws can be misused to
thwart stockholder choice and entrench the existing board of directors. To pass
judicial review, bylaws must, as a matter of equity, “be reasonable in their
application” and not unfairly interfere with stockholder voting.144
141 285 A.2d 437, 439 (Del. 1971). 142 See In re Invs. Bancorp, Inc. S’holder Litig., 177 A.3d 1208, 1222 (Del. 2017) (“[D]irectors’ exercise of [their] authority must be done consistent with their fiduciary duties.”); Hollinger, 844 A.2d at 1077–78 (“In general, there are two types of corporate law claims. The first is a legal claim, grounded in the argument that corporate action is improper because it violates a statute, the certificate of incorporation, a bylaw or other governing instrument, such as a contract. The second is an equitable claim, founded on the premise that the directors or officers have breached an equitable duty that they owe to the corporation and its stockholders.”). 143 564 A.2d 651, 659 (Del. Ch. 1988). 144 Frantz, 501 A.2d at 407 (citing Schnell, 285 A.2d at 407); Hubbard v. Hollywood Park Realty Enterprises, Inc., 1991 WL 3151, at *11 (Del. Ch. Jan. 14, 1991) (holding that an advance notice bylaw must “afford the shareholders a fair opportunity to nominate candidates”).
35 C.
In Coster v. UIP Companies, Inc., we folded Schnell and Blasius review into
Unocal enhanced scrutiny review when a board interferes with a corporate election
or a stockholder’s voting rights in contests for control.145 If a board adopts, amends,
or enforces advance notice bylaws during a proxy context, Coster requires a two-
part analysis. As explained in Coster, for the first step:
the court should review whether the board faced a threat “to an important corporate interest or to the achievement of a significant corporate benefit.” The threat must be real and not pretextual, and the board’s motivations must be proper and not selfish or disloyal. As Chancellor Allen stated long ago, the threat cannot be justified on the grounds that the board knows what is in the best interests of the stockholders.146
145 300 A.3d at 672 (citing Unocal Corp. v. Mesa Petroleum Co., 493 A.2d 946 (Del. 1985)). Prior to our decision in Coster, there was debate in the Court of Chancery over whether Blasius’ “compelling justification” standard should function as an independent standard of review from enhanced scrutiny review. See, e.g., Mercier v. Inter-Tel (Delaware), Inc., 929 A.2d 786, 788 (Del. Ch. 2007) (stating that, rather than functioning as a standard of review, Blasius was more an “an after-the-fact label placed on a result”); Chesapeake Corp. v. Shore, 771 A.2d 293, 323 (Del. Ch. 2000) (“Given this interrelationship and the continued vitality of Schnell v. Chris–Craft, one might reasonably question to what extent the Blasius ‘compelling justification’ standard of review is necessary as a lens independent of or to be used within the Unocal frame.”). Blasius is now subsumed in enhanced scrutiny review. 300 A.3d at 672. 146 300 A.3d at 672 (quoting Phillips v. Insituform of N. Am., Inc., 1987 WL 16285, at *7 (Del. Ch. Aug. 27, 1987)). “When Unocal is applied in this context, it can ‘subsume[ ] the question of loyalty that pervades all fiduciary duty cases, which is whether the directors have acted for proper reasons’ and ‘thus address[ ] issues of good faith such as were at stake in Schnell.’” Id. (alterations in original) (quoting Mercier, 929 A.2d at 807).
36 If the board adopted advance notice bylaws for a selfish or disloyal motive –
meaning for the primary purpose of precluding a challenge to its control – the
remedy is to declare the advance notice bylaws inequitable and unenforceable.147
Second, if the board’s actions pass muster under the first step of enhanced
scrutiny review, then the court considers:
whether the board’s response to the threat was reasonable in relation to the threat posed and was not preclusive or coercive to the stockholder franchise. To guard against unwarranted interference with corporate elections or stockholder votes in contests for corporate control, a board that is properly motivated and has identified a legitimate threat must tailor its response to only what is necessary to counter the threat. The board’s response to the threat cannot deprive the stockholders of a vote or coerce the stockholders to vote a particular way.148
147 Schnell, 285 A.2d at 437; see Frantz, 501 A.2d at 407 (“Schnell prohibits incumbent management from entrenching itself by taking action which, though legally possible, is inequitable.”). MM Companies, Inc. v. Liquid Audio, Inc., 813 A.2d 1118, 1132 (Del. 2003) (citing Schnell, 285 A.2d at 439) (holding that a bylaw amendment expanding the board’s size was intended to interfere with the stockholder franchise, invalidating the appointment of new board members, thereby rendering the expansion bylaw unenforceable); AB Value Partners, LP v. Kreisler Mfg. Corp., 2014 WL 7150465, at *5 (Del. Ch. Dec. 16, 2014) (holding that “[p]laintiff must provide compelling facts indicating that enforcement of the [advance notice bylaw] is inequitable” to enjoin application of an otherwise valid bylaw under Schnell); Hollinger, 844 A.2d at 1081 (finding bylaw amendments implemented by controller to facilitate a favored transaction and neutralize board’s opposition “were clearly adopted for an inequitable purpose and have an inequitable effect”); Hubbard, 1991 WL 3151, at *13 (ordering waiver of an advance notice bylaw to allow shareholders to nominate an opposing director slate in response to a material change in company policy instituted after nomination deadline); Lerman v. Diagnostic Data, Inc., 421 A.2d 906, 914 (Del. Ch. 1980) (holding that a 70-days’ notice bylaw was inequitable in a situation where the board announced the annual meeting only 63 days before it was to occur, rendering compliance impossible); Linton v. Everett, 1997 WL 441189, at *10 (Del. Ch. July 31, 1997) (“[D]irectors’ decision to provide only thirty days’ notice, which would inevitably trigger the advance notice provision in a manner foreseeably adverse to any shareholders desiring to nominate an opposing slate, constituted an inequitable manipulation of the election process.”). 148 Coster, 300 A.3d at 672 (citing Blasius, 564 A.2d at 656).
37 Enhanced scrutiny review ensures that a board’s actions are sufficiently
tailored to the threat at hand such that the act does not unfairly impede the free
exercise of the stockholder franchise.149 If a board is motivated to counter a
legitimate threat, but its response is disproportionate, the Court of Chancery has the
discretion to impose an equitable remedy.150 In the context of advance notice
bylaws, if the bylaws were adopted for a proper purpose but some of the advance
notice provisions were disproportionate to the threat posed and preclusive, the Court
of Chancery has the discretion to decide whether to enforce, in whole or in part, the
bylaws that can be applied equitably.151
149 Id. (“Unocal can also be applied with the sensitivity Blasius review brings to protect the fundamental interests at stake – the free exercise of the stockholder vote as an essential element of corporate democracy.”). 150 Following proportionality review, the Court of Chancery “has broad power to fashion an equitable remedy.” Unitrin, Inc. v. Am. Gen. Corp., 651 A.2d 1361, 1391 (Del. 1995); see also Gotham Partners, L.P. v. Hallwood Realty Partners, L.P., 817 A.2d 160, 176 (Del. 2002) (“[T]he Court of Chancery’s ‘powers are complete to fashion any form of equitable and monetary relief as may be appropriate.’” (quoting Weinberger v. UOP, Inc., 457 A.2d 701, 714 (Del. 1983))). 151 Kellner relies on Unitrin to argue that all defensive actions by a board must stand and fall together. In Unitrin, we held that when defensive actions are “inextricably related,” they should be “scrutinized collectively” under the proportionality prong of Unocal. 651 A.2d at 1387. Unitrin’s relatedness language refers to the method of analysis, not a limitation on what relief is available. Id. at 1391. As noted in the current case, it may be necessary to assess how bylaws work together, but one problematic bylaw does not invalidate others when the board has a proper motive. Overbroad invalidation would be extreme and unnecessary when the board acted with proper motive to protect a legitimate corporate interest. Kellner, 307 A.3d at 1037 & n.331. Unitrin does not require an all-or-nothing approach to relief but rather stresses that defensive actions should be assessed “individually and collectively.” 651 A.2d at 1390. Just as the Court of Chancery will not endorse a tripwire against an activist stockholder, it should not endorse a reverse tripwire by the activist. See also Mentor Graphics Corp. v. Quickturn Design Sys., Inc., 728 A.2d 25, 44 & n.47 (Del. Ch.), aff’d sub nom. Quickturn Design Sys., Inc. v. Shapiro, 721 A.2d 1281 (Del. 1998) (after determining that there was no dispute as to motive, that under enhanced scrutiny,
38 The Coster two-part enhanced scrutiny review – first, discerning a threat and
board motive, and second, determining whether the board’s actions were
proportionate to the threat posed and not preclusive or coercive – is meant to balance
the legitimate concerns of the board to respond to real threats with the equally
legitimate concern of allowing fully-informed stockholders to have the final say. As
stated in Unocal:
The restriction placed upon a [defensive measure] is that the directors may not have acted solely or primarily out of a desire to perpetuate themselves in office. Of course, to this is added the further caveat that inequitable action may not be taken under the guise of law. Schnell v. Chris-Craft Industries, Inc., Del.Supr., 285 A.2d 437, 439 (1971). The standard of proof . . . is designed to ensure that a defensive measure to thwart or impede a takeover is indeed motivated by a good faith concern for the welfare of the corporation and its stockholders, which in all circumstances must be free of any fraud or other misconduct. . . . However, this does not end the inquiry. A further aspect is the element of balance. If a defensive measure is to come within the ambit of the business judgment rule, it must be reasonable in relation to the threat posed.152 III.
In this appeal, it is apparent that confusion existed in the Court of Chancery
between a “validity” challenge and an “enforceability” challenge. Some of that
the court held that a bylaw amendment could operate equitably, but not a redemption plan); QVC Network, Inc. v. Paramount Commc’ns Inc., 635 A.2d 1245, 1271 (Del. Ch.), aff’d and remanded, 637 A.2d 828 (Del. 1993) (enjoining most, but not all defensive measures taken by the board in responding to a corporate takeover). 152 493 A.2d at 955 (citations omitted).
39 confusion might be attributed to how courts, including this Court, have used different
words or expressions to describe the outcome of a successful bylaw challenge.153
The Court of Chancery understood that Kellner “argue[d] that the Amended Bylaws
are invalid,” and assessed whether the Amended Bylaws were “facially valid.”154
But instead of undertaking a facial validity analysis, the court employed enhanced
scrutiny review to declare four of six Amended Bylaws invalid. The court relied on
153 The confusion stems from the use of different words or expressions like invalid, void, inequitable, unenforceable, nullified, struck down, and no force and effect. The choice of words has been imprecise regarding the “thorny area” of voidness. Holifield v. XRI Inv. Holdings LLC, 304 A.3d 896, 930 (Del. 2023). For example, in Hollinger, the Court of Chancery referred to bylaw amendments as being “inequitable,” “ineffective,” “of no force and effect,” and “struck down.” 844 A.2d 1022. This Court in Frantz equated “strik[ing] down” a bylaw with rendering it “void.” 501 A.2d at 407. Other decisions have described the exercise of the board’s authority under a facially valid but inequitable bylaw as being “nullif[ied],” “invalid,” and “not being permitted to stand.” Schnell, 285 A.2d at 440 (nullifying the change in a meeting date for a stockholder vote, under a legal bylaw); Liquid Audio, 813 A.2d at 1132 (invalidating a board expansion carried out under a valid bylaw). As described above, a facially valid bylaw must be consistent with the DGCL, the certificate of incorporation, and not otherwise prohibited by law. 8 Del. C. § 109(b). An invalid bylaw is ab initio void. See Michelson v. Duncan, 407 A.2d 211, 218–19 (Del. 1979) (“The essential distinction between voidable and void acts is that the former are those which may be found to have been performed in the interest of the corporation but beyond the authority of management, as distinguished from acts which are ultra vires . . . .”). A valid bylaw, when inequitable, is rendered unenforceable. See, e.g., Hollinger, 844 A.2d 1022; Hubbard, 1991 WL 3151, at *13 (enjoining the board’s use of a valid bylaw after conducting review under Blasius and Schnell). See also Liquid Audio, 813 A.2d at 1132 (“At issue in this case is not the validity generally of either a bylaw that permits a board of directors to expand the size of its membership or a board’s power to appoint successor members to fill board vacancies. In this case, however, the incumbent board timed its utilization of these otherwise valid powers to expand the size and composition of the Liquid Audio board for the primary purpose of impeding and interfering with the efforts of the stockholders’ power to effectively exercise their voting rights in a contested election for directors.”). 154 Kellner, 307 A.3d at 1021.
40 several hypothetical scenarios where the bylaws would be patently unreasonable if
applied in that fashion.155
When a validity challenge is raised, as might have been the case here, the
court should undertake an analysis distinct from enhanced scrutiny review.156 As
explained earlier, to assess validity, the court reviews whether the bylaw is contrary
to law or the certificate of incorporation and addresses a proper subject matter.157 A
bylaw is presumed valid, and the court should not consider hypotheticals or
speculate whether the bylaw might be invalid under certain circumstances. Instead,
the burden is on the party asserting invalidity to demonstrate that the bylaw cannot
be valid under any circumstance.158
Here, with one exception, we have no trouble concluding that the Amended
Bylaws are valid. As explained earlier, under the DGCL, and as provided in AIM’s
155 Id. at 1027–35 (conducting a proportionality analysis of the AAU Provision, Consulting/Nominating Provision, Known Supporter Provision, and Ownership Provisions). 156 We do not fault the Court of Chancery for the confusion. It appears that the parties were less than clear about the nature of their claims. Kellner argues that this Court has applied enhanced scrutiny to invalidate bylaws through “adoption” claims. Reply Br. at 34. In each of the decisions cited, the reviewing court either held the bylaw unenforceable, not invalid or void – or invalidated a corporate act which misused a valid bylaw. Schnell, 285 A.2d at 439–40; Liquid Audio, 813 A.2d at 1132; Blasius, 564 A.2d at 655 (invalidating an act, not a bylaw); In re Williams Companies S’holder Litig., 2021 WL 754593, at *40 (Del. Ch. Feb. 26, 2021), aff’d sub. nom. Williams Cos., Inc. v. Wolosky, 264 A.3d 641 (Del. 2021) (TABLE) (holding an inequitable shareholder rights plan unenforceable). 157 ATP, 91 A.3d at 558. 158 Id. See also Salzberg, 227 A.3d at 113 (applying the same rule for charter provisions).
41 certificate of incorporation, the directors have the “power to adopt, amend or repeal
bylaws.”159 Kellner has not argued that the AIM board lacked such power. And
AIM’s bylaws “may contain any provision, not inconsistent with law or with the
certificate of incorporation, relating to the business of the corporation, the conduct
of its affairs, and its rights or powers or the rights or powers of its stockholders,
directors, officers or employees.”160 Kellner has not argued that the Amended
Bylaws are outside the broad subject matter permitted by the General Assembly.
With one exception, the Amended Bylaws are valid.
The one exception is the Ownership Provision. The Court of Chancery
concluded that the 1,099-word single-sentence provision was “indecipherable.”161
We agree. The bylaw, with its thirteen discrete parts, is excessively long, contains
vague terms, and imposes virtually endless requirements on a stockholder seeking
to nominate directors.162 AIM’s chairman stated “that the bylaw was written in such
159 8 Del. C. § 109(a). 160 Id. § 109(b). 161 Kellner, 307 A.3d at 1034 (“Though I have tried to read and understand it, the bylaw—with its 1,099 words and 13 subparts—is indecipherable.”). 162 The defendants do not meaningfully defend the structure or drafting of the bylaw, only its subject matter. Answering Br. at 39. The court considered the subject matter of the bylaw and concluded that “[a]ny justifiable objectives that might be served by aspects of the Ownership Provision are buried under dozens of dense layers of text.” Kellner, 307 A.3d at 1035.
42 a way that “no one would read it.”163 As he testified, if the directors had started
reading it “line by line” during their March 2023 board meeting, they “would still
be in the meeting.”164 An unintelligible bylaw is invalid under “any
circumstances.”165
IV.
The Court of Chancery found that, before amending AIM’s bylaws, the board
“had an objective of obtaining transparency from a stockholder seeking to nominate
director candidates.”166 The court also found that the AIM board made a reasonable
assessment that its current advance notice bylaws were insufficient to prevent a
repeat of the manipulative, misleading, and improper conduct in the 2022
nomination process.167
Given the insurgents’ troubling history, we agree with the Court of Chancery
that there was a threat to the board’s information-gathering function, and that the
163 Kellner, 307 A.3d at 1034 (quoting the record). 164 Id. (quoting the record). 165 The defendants argue that Kellner did not “bring a facial relief claim” and therefore the Court of Chancery should not have invalidated any of the bylaws. Answering Br. at 30. As Kellner points out, he challenged the Amended Bylaws’ adoption, and with respect to the Ownership Provision, he correctly argued that “it fails any and every standard of review.” Reply Br. at 35, 45. In any case, the defendants put the issue before the court when they sought a declaration that the bylaws are “valid and lawful.” Dfs.’ Ans. Ver. Compl. and Ver. CC. at 100. 166 Kellner, 307 A.3d at 1026. 167 Id.
43 AIM board identified an important corporate objective in amending its bylaws –
transparency in board elections. The court also found, however, that the AIM board
likely acted with an improper purpose when adopting the Amended Bylaws that,
unsurprisingly, were used to reject Kellner’s nomination, most notably the AAU
Of the six Amended Bylaws that are the focus of this appeal, one was
nonsensical and therefore invalid. According to the Court of Chancery, the invalid
bylaw “seem[ed] designed to preclude a proxy contest for no good reason; none were
given.”168 The court also found that, in essence, the AIM board acted inequitably
when it adopted the three remaining Amended Bylaws. It observed that the bylaws
“suggest[ed] an intention to block the dissident’s effort,”169 were “akin to a
tripwire,”170 could be “draconian,”171 and “exceed[ed] any reasonable approach to
ensuring thorough disclosure.”172 The court concluded that, when the AIM board
adopted various advance notice provisions in the Amended Bylaws, their actions
168 Id. at 1034–35. 169 Id. at 1031. 170 Id. at 1030. 171 Id. at 1031. 172 Id. at 1032.
44 “seem[ed] designed to thwart an approaching proxy contest, entrench the
incumbents, and remove any possibility of a contested election.”173
We consider these findings dispositive on appeal to the enhanced scrutiny
motive inquiry. As explained below, the Court of Chancery’s assessment about the
unreasonableness of a majority of the Amended Bylaws lead us to conclude that the
AIM board amended its bylaws for an improper purpose – to thwart Kellner’s proxy
contest and maintain control.174 The board’s conduct fails the first prong of
The AAU Provision required the disclosure of all arrangements, agreements,
or understandings, “whether written or oral, and including promises,” relating to a
board nomination.175 The Court of Chancery found the SAP term unreasonable.176
It noted that the “Holder” SAP definition included:
173 Id. at 1036. 174 We limit our ruling to the six Amended Bylaws on appeal. Other bylaws were amended for different purposes and were not challenged on appeal. As the court noted, “[c]ertain of the Amended Bylaws reflect changes to address Rule 14a-19 and cohere with the DGCL,” and are unaffected by our decision. Kellner, 307 A.3d at 1025. 175 A409. 176 Kellner, 307 A.3d at 1030.
45 (i) any person acting in concert with such Holder with respect to the Stockholder Proposal or the Corporation, (ii) any person controlling, controlled by, or under common control with such Holder or any of their respective Affiliates and Associates, or a person acting in concert therewith with respect to the Stockholder Proposal or the Corporation, and (iii) any member of the immediate family of such Holder or an Affiliate or Associate of such Holder.177 The SAP provision, according to the court, created an ill-defined web of
disclosure requirements through the interaction of terms such as “acting in concert,”
“Associate,” “Affiliate,” and “immediate family.”178 The defendants argue on
appeal that the AAU Provision is equitable because the board relied on counsel and
had a legitimate objective in seeking multi-level relationships among the activists.179
They contend that the AAU does not require knowledge the nominator does not
know and could not obtain.180 We disagree. As the Court of Chancery determined,
the SAP term in the AAU Provision requires a nominator to disclose not only
personal knowledge but also to take steps to gather information about agreements
and understandings between any members of potentially limitless class of third
parties and individuals unknown to the nominator.181
177 A412. 178 Kellner, 307 A.3d at 1030. 179 Answering Br. at 37. 180 Id. at 36. 181 Kellner, 307 A.3d at 1030.
46 We agree with the Court of Chancery that the AAU Provision, as drafted, did
not further the AIM board’s stated purpose of preventing stockholders from
misconstruing or evading the Amended Bylaws’ disclosure requirements. Instead,
it functioned as a “tripwire” rather than an information-gathering tool and
“suggest[ed] an intention to block the dissidents’ effort.”182
Next, the court determined that the Consulting/Nomination Provision was
unreasonable.183 The provision required disclosure of AAUs spanning a ten-year
window “between the nominating stockholder or an SAP, on one hand, and any
stockholder nominee, on the other hand, regarding consulting, investment advice, or
a previous nomination for a publicly traded company within the last ten years.”184
The court held that the bylaw suffers from the same SAP problem as the AAU
Provision by imposing “ambiguous requirements,” this time “across a lengthy
term.”185
182 Id. at 1031. The court, after invalidating the AAU Provision, applied the 2016 AAU Provision to reject the notice. As we have determined, the AAU Provision is still valid, even if unenforceable, and thus a reversion to the 2016 bylaw is not possible. 183 Kellner, 307 A.3d at 1031. 184 Id. (citing A409). 185 Id.
47 The court also held that the Provision was unreasonable because it sought
AAUs involving other publicly traded companies over an onerous ten-year period
and between and among a broadly defined set of third parties. The defendants argue
that the court’s reading is incorrect and that the provision only sought information
involving the nominee.186 We disagree. The provision requires the nominating
stockholder to disclose, as to each nominee, AAUs between or among each
nominator and/or any SAP, and the nominee.187 This is not just a requirement to
disclose AAUs involving the nominee, but also among the vague categories of SAPs
and the nominee.
The defendants do not address the problematic lengthy ten-year term
encompassing any public company. AIM’s Chairman characterized the relevance
of the information sought by the Provision as “arguable.”188 We agree with the Court
of Chancery that the Provision imposed ambiguous requirements across a lengthy
term; sought only marginally useful information; gave the board “license to reject a
notice” based on a subjective interpretation of its imprecise terms; and, at worst, was
“draconian.”189
186 Answering. Br. at 38. 187 A409. 188 Kellner, 307 A.3d at 1031(quoting the record). 189 Id. at 1030.
48 C.
The Court of Chancery was also troubled by the unreasonableness of the
Known Supporter Provision, which requires the nominator and nominees to list any
person who acted in “support” of a stockholder proposal.190 The defendants argue
that this provision is similar in scope and purpose to a bylaw approved by the Court
of Chancery in Rosenbaum v. CytoDyn, Inc.191 The court observed that, unlike the
CytoDyn bylaw, which only sought disclosure of known “financial support” from
stockholders, the AIM provision operates more broadly and seeks disclosure of any
support whatsoever from both stockholders and SAPs.192
The defendants point out that the bylaw in CytoDyn and the Known Supporter
Provision use virtually identical language.193 Even so, the court took issue with the
use of the troubling SAP term in the bylaw, which rendered the bylaw’s requirements
190 Id. (citing A409). 191 2021 WL 4775140, at *19 (approving a bylaw that mandated disclosure of supporters). 192 Kellner, 307 A.3d at 1032. 193 Compare CytoDyn, 2021 WL 4775140, at *9 (“[I]dentification of the names and addresses of other stockholders (including beneficial owners) known by any of the Proposing Persons to support nominations or other business proposal(s), and to the extent known the class and number of all shares of the Corporations’ capital stock owned beneficially or of record by such other stockholder(s) or other beneficial owner(s) . . . .”), with Kellner, 307 A.3d at 1031 n.306 (“the names (including, if known, the full legal names and any alias names used) and addresses of other stockholders (including beneficial owners) known by any Holder or Stockholder Associated Person to support such Stockholder Proposal or Stockholder Proposals (including, without limitation, any nominations), and to the extent known, the class or series and number of all shares of the Corporation’s capital stock owned beneficially or of record by each such other stockholder or other beneficial owner.”).
49 far more expansive than the one at issue in CytoDyn. Like the AAU Provision, the
nominating stockholder must not only respond based on personal knowledge, but
also an ill-defined daisy chain of persons. We agree with court’s conclusion that the
Known Supporter Provision “impedes the stockholder franchise while exceeding
any reasonable approach to ensuring thorough disclosure.”194
We have also described earlier the problematic nature of the Ownership
Provision. As the court held, it is “unintelligible” and “seems designed to preclude
a proxy contest for no good reason; none were given.”195 A stockholder “could not
fairly be expected to comply.”196
V.
In the middle of a proxy contest, the AIM board adopted one unintelligible
bylaw and three unreasonable bylaws. It then used the Amended Bylaws to reject
Kellner’s nomination notice. The Court of Chancery found that the Amended
Bylaws “seem[ed] designed to thwart an approaching proxy contest, entrench the
incumbents, and remove any possibility of a contested election.”197 It also observed
194 Kellner, 307 A.3d at 1031. 195 Id. at 1034–35. 196 Id. 197 Id. at 1036.
50 that the Amended Bylaws precluded stockholders, such as Kellner, from a “fair
opportunity to nominate candidates.”198 The unreasonable demands of most of the
Amended Bylaws show that the AIM board’s motive was not to counter the threat
of an uninformed vote. Rather, the board’s primary purpose was to interfere with
Kellner’s nomination notice, reject his nominees, and maintain control. As the
product of an improper motive and purpose, which constitutes a breach of the duty
of loyalty, all the Amended Bylaws at issue in this appeal are inequitable and
therefore unenforceable.199
We also note that, according to the Court of Chancery, Kellner submitted false
and misleading responses to some of the requests.200 Given the court’s
countervailing findings about Kellner’s and his nominees’ deceptive conduct, no
further action is warranted. The judgment of the Court of Chancery is affirmed in
part and reversed in part. The case is closed.
198 Id. at 1036. 199 Kreisler Mfg. Corp., 2014 WL 7150465, at *5 (“The clearest set of cases providing support for enjoining an advance notice bylaw involves a scenario where a board, aware of an imminent proxy contest, imposes or applies an advance notice bylaw so as to make compliance impossible or extremely difficult, thereby thwarting the challenger entirely.”). 200 Kellner, 307 A.3d at 1039–40 & n.353 (finding that Kellner’s AAU disclosures were “false” and “omitted and misrepresented meaningful AAUs,” and that the 2022 AAU disclosures concealed Tudor’s role in the nomination process); Kellner v. AIM ImmunoTech Inc., 2024 WL 62666, at *2 (Del. Ch. Jan. 5, 2024) (Letter Op.) (“The resolution of that claim turned on factual findings that arrangements or understandings animating Kellner’s nomination were obfuscated from AIM’s board and stockholders. Kellner was required to disclose these arrangements or understandings. He did not.”).
Related
Cite This Page — Counsel Stack
Ted D. Kellner v. AIM ImmunoTech Inc., Counsel Stack Legal Research, https://law.counselstack.com/opinion/ted-d-kellner-v-aim-immunotech-inc-del-2024.